RAPT files corporate presentation with no material new disclosures

RAPT Therapeutics, Inc.

Filed investor presentation slides as Exhibit 99.1 under Item 7.01 Regulation FD.
No specific financial results, guidance, or clinical data milestones announced.
Presentation likely covers inflammation science; no new facts extracted from limited exhibit text.

item 7.01item 9.01

Source: SEC EDGAR

accession 0000950170-25-083762

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.